Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Lung Non-Small Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04732520
What this trial is testing

Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Galvanize Therapeutics, Inc. 47
Not applicableStudy completedNCT01985113
What this trial is testing

Correlation Research of Thioredoxin Reductase in Lung Cancer

Who this might be right for
Non-small Cell Lung CancerBenign Neoplasm of Lung
Hunan Province Tumor Hospital 165
Testing effectiveness (Phase 2)Study completedNCT00750269
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 120
Large-scale testing (Phase 3)Active Not RecruitingNCT03703297
What this trial is testing

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Who this might be right for
Small Cell Lung Cancer
AstraZeneca 730
Not applicableLooking for participantsNCT04654364
What this trial is testing

Lung Cancer Registry

Who this might be right for
Lung CancerNSCLC Stage IVNSCLC, Stage III+2 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 500
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Post-approval studies (Phase 4)Ended earlyNCT04381494
What this trial is testing

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

Who this might be right for
Unresectable Stage III NSCLC
AstraZeneca 40
Testing effectiveness (Phase 2)Ended earlyNCT04638582
What this trial is testing

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Nonsmall Cell
McGill University Health Centre/Research Institute of the McGill University Health Centre 6
Not applicableWithdrawnNCT01398124
What this trial is testing

Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Milton S. Hershey Medical Center
Not applicableStudy completedNCT02488850
What this trial is testing

Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Erasmus Medical Center 32
Large-scale testing (Phase 3)Study completedNCT00373425
What this trial is testing

Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors

Who this might be right for
Non-small Cell Lung Cancer
OSI Pharmaceuticals 1,252
Not applicableLooking for participantsNCT06743581
What this trial is testing

Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy
Centre hospitalier de l'Université de Montréal (CHUM) 24
Testing effectiveness (Phase 2)Study completedNCT00462995
What this trial is testing

Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)

Who this might be right for
Non Small Cell Lung Cancer
University Health Network, Toronto 25
Not applicableLooking for participantsNCT07564557
What this trial is testing

Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)

Who this might be right for
Non-small Cell Lung CancerEarly-stage Lung CancerDeep-seated Lung Nodules+1 more
Shanghai Chest Hospital 89
Early research (Phase 1)Study completedNCT03509012
What this trial is testing

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckCarcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma
AstraZeneca 105
Not applicableLooking for participantsNCT07743021
What this trial is testing

Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data

Who this might be right for
Non-communicable Diseases (NCD)NeoplamsCancer+11 more
Center for Molecular Fingerprinting Research Nonprofit LLC 15,000
Large-scale testing (Phase 3)Study completedNCT00775385
What this trial is testing

TAilored Post-Surgical Therapy in Early Stage NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 152
Early research (Phase 1)WithdrawnNCT06427369
What this trial is testing

An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung CancerLimited-stage Small-cell Lung CancerLung Non-Small Cell Carcinoma+2 more
Roswell Park Cancer Institute
Not applicableLooking for participantsNCT03706027
What this trial is testing

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

Who this might be right for
Lung Cancer
University of Rochester 100
Not applicableUnknownNCT06250829
What this trial is testing

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Next Page